Trump eyes 2026 midterms as key 2024 races drive political climate, with Democrats holding early lead for control of Congress amid concerns over economy and constitutional protections.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Trump eyes 2026 midterms as key 2024 races drive political climate, with Democrats holding early lead for control of Congress amid concerns over economy and constitutional protections.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.